Annual breast cancer screening at 40 saves lives

Annual breast cancer screening starting at age 40 provides the greatest benefit to women with the least amount of risk, according to a study published in Radiology, a study of patients with anti-citrullinated protein antibodies and subclinical inflammatory changes in joints, published in The Lancet, has shown that 6-month treatment with abatacept can improve inflammation and decrease the risk of rheumatoid arthritis, and persistent false positive COVID-19 rapid antigen tests are rare, but possible.